BRIEF

on AMOEBA (EPA:ALMIB)

Amoéba Publishes its Half-Yearly Financial Report as of June 30, 2024

Stock price chart of AMOEBA (EPA:ALMIB) showing fluctuations.

The company Amoéba, specialized in microbiological solutions, has made available its half-yearly financial report for June 30, 2024. Announced on October 7, 2024, this document is accessible via the company's website.

The report, filed with the Autorité des marchés financiers, details the company's performance. Amoéba focuses on the biocontrol market for plant protection and the cosmetics sector, with an active substance recently approved in the United States and Europe.

Investors and interested parties can consult this report in the section dedicated to financial information on the Amoéba website. The company will also participate in the Biotech & Health Seminar on October 9, 2024, organized by Portzamparc BNP Paribas.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AMOEBA news